ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

5 Essential Facts Families Should Know About Lung Cancer Staging

photo

SPONSORED CONTENT -- (StatePoint) Close to 238,000 people in the United States will be diagnosed with lung cancer this year. That’s about one person every two and a half minutes. Fortunately, more Americans are surviving lung cancer thanks in part to early detection, groundbreaking research and new treatments. However, the path from diagnosis to treatment can be confusing. Advocates say that understanding lung cancer staging is essential to empowering patients and their families.

Lung cancer staging means finding out where the lung cancer cells are located, the size of the lung cancer nodules, and if and where lung cancer has spread.

“Accurate, thorough and timely staging of lung cancer directly impacts treatment options and prognosis,” says Harold Wimmer, president and CEO of the American Lung Association. “This is why it’s imperative to educate people on how this process works, so they can ask questions and advocate for the highest standard of care throughout the cancer journey.”

The American Lung Association and Olympus have partnered on a new educational campaign providing easy-to-digest information and resources to families facing lung cancer. As part of the campaign, they are sharing these important lung cancer staging facts:

1. There are three main scenarios in which lung nodules are found: Lung nodules are small masses of dense tissue that may be an indicator of lung disease. They show up on imaging tests like X-rays and CT scans in one of three ways: through lung cancer screening of high-risk patients, when patients have symptoms and physicians are looking for a cause, or when patients are being treated for other conditions. If a nodule is found, physicians look at its size, shape and the patient’s health history to determine next steps.

2. Sometimes waiting is recommended: Patients are often anxious to get started with treatment, but not every lung nodule needs to be treated. In some cases, the most appropriate next step is to re-scan the lungs in several months to see if there are changes.

3. Staging uses numbers and letters to describe how far the cancer has spread: If the nodule appears cancerous (malignant), physicians gather information to confirm the cancer and understand its type, size, location and spread. Based on this information, the lung cancer is diagnosed and then assigned a stage using numbers and the letters T, N and M—size of the primary tumor (T), the number and location of regional lymph nodes (N), and the presence or absence of metastasis (M).

4. Physicians need information before starting treatment: Physicians need to know exactly how far the cancer has spread, which lymph nodes are involved and if there are any biomarkers, to be able to recommend the most appropriate treatment. People should work closely with their care team to learn what to expect based on their cancer, and to understand the risks and benefits associated with each care decision.

5. New resources are available: Through this campaign, resources are available to provide more information about lung nodules at Lung.org/lung-nodules and staging at Lung.org/staging. In addition, the American Lung Association’s Lung Helpline is staffed with a Lung Cancer Patient Navigator to help answer any questions a person or their family may have.

“There is hope for each stage of lung cancer,” says Wimmer. “By understanding the different stages and the diagnosis process, individuals can have greater control of their care.”

*****

Photo Credit: (c) Lordn / iStock via Getty Images Plus

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.